Elicio Therapeutics's total assets for Q3 2024 were $38.39M, an increase of 143.73% from the previous quarter. ELTX total liabilities were $57.37M for the fiscal quarter, a 229.70% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.